Clinical Trial Update: A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE) [Phase 3]

View source ↗

Summary

This Phase 3 ENCORE trial evaluated switching Gaucher disease type 1 patients who had achieved therapeutic goals on enzyme replacement therapy to eliglustat tar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease Type

Drugs mentioned

• Eliglustat Tartrate (Eliglustat tartrate)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Gaucher Disease, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2014-09-04